Paclitaxel resistance by random mutagenesis of α-tubulin

Area of Science:

• Molecular Biology
• Cell Biology
• Genetics

Background:

• Paclitaxel resistance in mammalian cells is often linked to beta-tubulin mutations.
• The role of alpha-tubulin mutations in paclitaxel resistance remains largely uncharacterized.
• Previous studies indicated alpha-tubulin mutations occur frequently in paclitaxel-resistant cells.

Purpose of the Study:

• To identify and characterize alpha-tubulin mutations conferring paclitaxel resistance.
• To investigate the mechanism by which alpha-tubulin mutations affect drug resistance.
• To explore potential links between alpha-tubulin mutations, drug resistance, and human developmental disorders.

Main Methods:

• Sequencing of the major alpha-tubulin gene in paclitaxel-resistant Chinese hamster ovary (CHO) cell lines.
• Random mutagenesis and transfection of alpha-tubulin cDNA to generate resistant mutants.
• Site-directed mutagenesis to confirm the role of identified mutations in resistance.

Main Results:

• Five alpha-tubulin mutations were identified in the amino-terminal region of the protein.
• An additional 16 mutations were found throughout the alpha-tubulin sequence using random mutagenesis.
• Mutations were confirmed to confer resistance by reducing microtubule assembly.
• One mutation affected alpha-tubulin acetylation, similar to other resistance mutations.

Conclusions:

• Alpha-tubulin mutations are a significant factor in paclitaxel resistance.
• These mutations confer resistance by impairing microtubule assembly.
• Identified mutations share commonalities with genetic lesions in human brain disorders, suggesting a link to microtubule dysfunction.